Researchers discover a new diet-associated gut-microbe metabolite linked to cardiovascular disease

Cleveland Clinic researchers have identified a gut microbe-generated byproduct -- phenylacetylglutamine (PAG) -- that is linked to development of cardiovascular disease, including heart attack, stroke and death. The study was published in Cell today.